Population model successfully developed to characterize BI-1910 pharmacokinetics and pharmacodynamics across a broad range of ...

Linda Duska, MD, FASCO, MPH, discusses the importance of the KEYNOTE-A18 study reinforcing the new standard of care of pembrolizumab plus concurrent chemoradiotherapy in locally advanced cervical ...

Chinese doctors have reported a milestone in domestically made innovative medicine, announcing that a combination of ...

The accused individuals were selling spurious cancer medicines and injections, including Opdivo, Pembrolizumab Injection, Keytruda, and others, without proper authorisation. The police raided three ...

Since establishing an exclusive partnership in 2021, the Norne Carbon Storage Hub ("Norne"), a Fidelis New Energy, LLC ...

As a global leader in MicroLED microdisplay technology, JBD has announced that its proprietary, system-level image-quality engine for waveguide AR Glasses?ARTCs?has been fully integrated into RayNeo's ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, with tumours shrinking ...

Two-Part Dose Escalation and Expansion Trial Will Evaluate Efficacy and Safety of BYON4228 Alone and in Combination with Pembrolizumab NIJMEGEN, The ...

The ADC market was valued at $8.6bn in 2023, with it forecast to exceed $45bn by 2030, according to analysis by GlobalData.

AbbVie’s telisotuzumab dizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...

The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.